| Literature DB >> 30040425 |
Saroopa P Samaradivakara1, Radhika Samarasekera2, Shiroma M Handunnetti1, O V D S Jagathpriya Weerasena1, Ayad A Al-Hamashi, James T Slama, William R Taylor, Qasim Alhadidi, Zahoor A Shah, Lalith Perera3, L M Viranga Tillekeratne.
Abstract
A new resveratrol trimer, vateriferol (1), having four cis-oriented methine protons and constituting four contiguous stereocenters, was isolated from the bark extract of Vateria copallifera by bioassay-guided fractionation using a combination of normal, reversed phase, and size exclusion column chromatography. The structure was established based on its spectroscopic data. Vateriferol (1) was evaluated in vitro for its antioxidant capacity, enzyme inhibitory activity, growth inhibitory activity on a number of cancer cell lines, neuroprotective activity, and anti-inflammatory activity. Vateriferol (1) exhibited AChE inhibitory activity (IC50 8.4 ± 0.2 μM), ORAC activity (2079 ± 0.20 TE/g), and neuroprotective activity at 1.5 μM using PC12 cells deprived of oxygen and glucose and lowered NO levels in lipopolysaccharide-stimulated SIM-A9 microglial cells at 14.7 and 73.6 μM. Vateriferol (1) exhibited weak cytotoxic potency (<50% growth inhibition) against the tested cell lines at 147.2 μM.Entities:
Mesh：
Substances：
Year: 2018 PMID： 30040425 PMCID： PMC7015271 DOI： 10.1021/acs.jnatprod.7b00892
Source DB: PubMed Journal: J Nat Prod ISSN： 0163-3864 Impact factor: 4.050